Haemophagocytic visceral kala azar

Case Reports

A Rodriguez-Cuartero et al. Infection. 1991 May-Jun.

. 1991 May-Jun;19(3):184.

doi: 10.1007/BF01643248.

No abstract available

Similar articles

Visceral kala-azar associated with post-kala-azar dermal leishmaniasis.
Singh NK, Agrawal SK, Jha TK. Singh NK, et al. J Assoc Physicians India. 1989 Feb;37(2):191. J Assoc Physicians India. 1989. PMID: 2808294
Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
Lindoso JAL, Moreira CHV, Celeste BJ, Oyafuso LKM, Folegatti PM, Zijlstra EE. Lindoso JAL, et al. Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):105-107. doi: 10.1590/0037-8682-0487-2016. Rev Soc Bras Med Trop. 2018. PMID: 29513829
Pancytopenia in kala-azar.
Bada JL, Arderiu A, Gimenez J, Gomez-Acha JA. Bada JL, et al. Trans R Soc Trop Med Hyg. 1979;73(2):246-7. doi: 10.1016/0035-9203(79)90230-x. Trans R Soc Trop Med Hyg. 1979. PMID: 473318 No abstract available.
Treatment of post-kala-azar dermal leishmaniasis.
Ramesh V. Ramesh V. Int J Dermatol. 1994 Mar;33(3):153-6. Int J Dermatol. 1994. PMID: 8169009 Review. No abstract available.
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H, Sharma KK, Rijal S, Dwivedi S, Koirala S. Sangraula H, et al. J Assoc Physicians India. 2003 Jul;51:686-90. J Assoc Physicians India. 2003. PMID: 14621038 Review.

Case Report: Visceral Leishmaniasis-associated Hemophagocytic Lymphohistiocytosis in Adults: A Case Series and Literature Review.
Qin Y, Lv X, Zheng Q, Wu Q, Zheng L, Kang M, Liu T, He F. Qin Y, et al. Am J Trop Med Hyg. 2022 Nov 14;107(6):1203-1209. doi: 10.4269/ajtmh.22-0361. Print 2022 Dec 14. Am J Trop Med Hyg. 2022. PMID: 36375456 Free PMC article. Review.